- Home
- ALLE vs TECH Comparison
ALLE vs TECH Comparison
Compare ALLE & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALLE | TECH |
|---|---|---|
| Founded | 2013 | 1976 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 11.2B |
| IPO Year | 2013 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ALLE | TECH |
|---|---|---|
| Price | $165.64 | $72.13 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 11 |
| Target Price | ★ $167.13 | $71.82 |
| AVG Volume (30 Days) | 1.3M | ★ 3.4M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.60% | 0.62% |
| EPS Growth | ★ 9.09 | N/A |
| EPS | ★ 3.74 | 0.81 |
| Revenue | N/A | ★ $1,219,635,000.00 |
| Revenue This Year | $8.47 | $2.49 |
| Revenue Next Year | $4.58 | $6.40 |
| P/E Ratio | ★ $45.17 | $89.25 |
| Revenue Growth | N/A | ★ 5.23 |
| 52 Week Low | $125.00 | $43.20 |
| 52 Week High | $183.11 | $72.37 |
Technical Indicators
Market Signals| Indicator | ALLE | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 70.70 | 71.41 |
| Support Level | $162.88 | $70.49 |
| Resistance Level | $167.46 | $72.22 |
| Average True Range (ATR) | 4.40 | 0.28 |
| MACD | 1.16 | -0.53 |
| Stochastic Oscillator | 84.14 | 69.54 |
Price Performance
Historical ComparisonAbout ALLE Allegion plc
Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2024, Allegion generated over 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy, Switzerland-based Dormakaba, and US-based Fortune Brands Innovations.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.